The medical research field has a new entrant in the shape of Eric Lefkofsky’s Tempus company, which has recently made an impact in the development of new ways of exploring DNA in a bid to aid cancer treatments across the world. A well known technology entrepreneur, Eric Lefkofsky has created Tempus as he felt the use of technology could be increased in the medical field in an attempt to reduce the number of problems seen in the development of new treatments for cancer patients when DNA samples are used to their maximum efficiency.
In developing Tempus Eric Lefkofsky and business partner Brad Keywell hope to aid medical professionals with the treatment of cancer through the use of a database of DNA samples and its accompanying software; among the developments already in place is software that will allow medical professionals to compare DNA samples with those already stored on the database and determine if an effective treatment has already been developed for similar DNA samples. Eric Lefkofsky has revealed his desire for the work completed by Tempus to be used to prolong the lives of cancer patients and aid in developing new treatments that could include cures for those showing specific detail in their DNA sample.
Eric Lefkofsky spent his educational career at the University of Michigan, where he received an undergraduate degree and a Juris Doctor in Law; after completing his studies Lefkofsky set out to develop a number of technology companies and has achieved great success with many, including the establishment of the Groupon company that he is best known for developing.After standing down from his role as Chairperson of Groupon, Eric Lefkofsky has been concentrating on the development of the Tempus brand, which has followed on from his becoming a Trustee of the Lurie Children’s Hospital of Chicago. As a philanthropist Lefkofsky has worked across a number of different areas to assist a number of charitable groups, including The Art Institute of Chicago and the Science and Industry Museum that have both benefited from the impressive financial support offered by Eric Lefkofsky.